Copenhagen, Denmark – June 10, 2025 – Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the EU and US markets. The device addresses a critical need among nurses, who currently spend significant time manually flushing IV-lines to clear residual medication from IV lines.
The financing round marks the company’s first external investment and includes backing from leading healthcare investors, such as the former executive of ConvaTec, members of experienced MedTech family offices, and seasoned angel investors with nursing and clinical backgrounds.